Viking Therapeutics Stock (NASDAQ: VKTX) stock price, news, charts, stock research, profile.
Open | $69.000 |
Close | - |
Volume / Avg. | 1.518M / 6.351M |
Day Range | 68.220 - 71.500 |
52 Wk Range | 8.280 - 99.410 |
Market Cap | $7.562B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 11.64% |
Days to Cover | 1.65 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Viking Therapeutics (NASDAQ: VKTX) through any online brokerage.
Other companies in Viking Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by HC Wainwright & Co. on Thursday, April 25, 2024. The analyst firm set a price target for 90.00 expecting VKTX to rise to within 12 months (a possible 31.23% upside). 31 analyst firms have reported ratings in the last year.
The stock price for Viking Therapeutics (NASDAQ: VKTX) is $68.58 last updated Today at April 26, 2024 at 12:36 PM EDT.
There are no upcoming dividends for Viking Therapeutics.
Viking Therapeutics’s Q2 earnings are confirmed for Wednesday, July 24, 2024.
There is no upcoming split for Viking Therapeutics.
Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.